Table 2.

Demographic characteristics of the patients whose primary tumour cells were derived and exposed in vitro to obatoclax

Number of cases	39
Median Age, years (range)	62 (24–83)
Sex:
Male	25 (64%)
Female	14 (36%)
Diagnosis:
DLBCL	15
GCB DLBCL	6
Non-GCB DLBCL	9
FL	12
LPHL	2
SLL/MZL/MCL	6
Lymphoid Hyperplasia	4
Disease Status:
De Novo	22 (56%)
Relapsed/Refractory	17 (44%)
Prior rituximab therapy	35%

DLBCL = Diffuse Large B-cell Lymphoma

GCB = Germinal Centre B-cell

FL = Follicular Lymphoma

LPHL = Lymphocyte predominant Hodgkin lymphoma

SLL = Small Lymphocytic Lymphoma

MZL = Marginal Zone Lymphoma

MCL = Mantle Cell Lymphoma